Circ_0062270 accelerated the progression of melanoma through regulating the miR-331-3p/EPHA2 axis, suggesting that circ_0062270 might be a novel potential therapeutic target for melanoma.
Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p.